These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 35665866)
21. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma. Zhou R; Peng N; Li W Front Immunol; 2022; 13():964919. PubMed ID: 36059494 [TBL] [Abstract][Full Text] [Related]
22. Identification of two molecular subtypes of dysregulated immune lncRNAs in ovarian cancer. Liu X; Gao J; Wang J; Chu J; You J; Jin Z Exp Biol Med (Maywood); 2021 Mar; 246(5):547-559. PubMed ID: 33203236 [TBL] [Abstract][Full Text] [Related]
23. Computational construction of TME-related lncRNAs signature for predicting prognosis and immunotherapy response in clear cell renal cell carcinoma. Zhou L; Fang H; Guo F; Yin M; Long H; Weng G J Clin Lab Anal; 2022 Aug; 36(8):e24582. PubMed ID: 35808868 [TBL] [Abstract][Full Text] [Related]
24. Comprehensive analysis of immune-related lncRNAs and their clinical relevance in gastric adenocarcinoma. Jin Y; Ma J; Wang L Funct Integr Genomics; 2023 Jan; 23(1):28. PubMed ID: 36598654 [TBL] [Abstract][Full Text] [Related]
25. The linkage of NF-κB signaling pathway-associated long non-coding RNAs with tumor microenvironment and prognosis in cervical cancer. Feng X; Shan R; Hu X BMC Med Genomics; 2023 Jul; 16(1):169. PubMed ID: 37461017 [TBL] [Abstract][Full Text] [Related]
26. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer. Mao C; Gao Y; Wan M; Xu N Funct Integr Genomics; 2022 Aug; 22(4):597-609. PubMed ID: 35420332 [TBL] [Abstract][Full Text] [Related]
27. A Five-gene Signature based on MicroRNA for Predicting Prognosis and Immunotherapy in Stomach Adenocarcinoma. Wang T; Chen P; Li T; Li J; Zhao D; Meng F; Zhao Y; Zheng Z; Liu X Curr Med Chem; 2024; 31(17):2378-2399. PubMed ID: 38310388 [TBL] [Abstract][Full Text] [Related]
28. Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination. You W; Ouyang J; Cai Z; Chen Y; Wu X Front Immunol; 2022; 13():827506. PubMed ID: 35874675 [TBL] [Abstract][Full Text] [Related]
29. Immune Subtype Profiling and Establishment of Prognostic Immune-Related lncRNA Pairs in Human Ovarian Cancer. Wang X; Wang J; Yu M Comput Math Methods Med; 2022; 2022():8338137. PubMed ID: 35578596 [TBL] [Abstract][Full Text] [Related]
30. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma. Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459 [TBL] [Abstract][Full Text] [Related]
31. Exploring the Potential of Exosome-Related LncRNA Pairs as Predictors for Immune Microenvironment, Survival Outcome, and Microbiotain Landscape in Esophageal Squamous Cell Carcinoma. Zhao F; Li Z; Dong Z; Wang Z; Guo P; Zhang D; Li S Front Immunol; 2022; 13():918154. PubMed ID: 35880180 [TBL] [Abstract][Full Text] [Related]
32. Construction of subtype classifiers and validation of a prognostic risk model based on hypoxia-associated lncRNAs for lung adenocarcinoma. Hui H; Li D; Lin Y; Miao H; Zhang Y; Li H; Qiu F; Jiang B J Thorac Dis; 2023 Jul; 15(7):3919-3933. PubMed ID: 37559652 [TBL] [Abstract][Full Text] [Related]
33. N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment. Zheng J; Zhao Z; Wan J; Guo M; Wang Y; Yang Z; Li Z; Ming L; Qin Z J Clin Lab Anal; 2021 Nov; 35(11):e23951. PubMed ID: 34558724 [TBL] [Abstract][Full Text] [Related]
34. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets. Ren N; Liang B; Li Y Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33015704 [TBL] [Abstract][Full Text] [Related]
35. A novel classification of HCC basing on fatty-acid-associated lncRNA. Xu Y; Yu X; Zhang Q; He Y; Guo W Sci Rep; 2022 Nov; 12(1):18863. PubMed ID: 36344648 [TBL] [Abstract][Full Text] [Related]
36. Characterization and validation of a ferroptosis-related LncRNA signature as a novel prognostic model for lung adenocarcinoma in tumor microenvironment. Wang Y; Lu G; Xue X; Xie M; Wang Z; Ma Z; Feng Y; Shao C; Duan H; Pan M; Ding P; Li X; Han J; Yan X Front Immunol; 2022; 13():903758. PubMed ID: 36016939 [TBL] [Abstract][Full Text] [Related]
37. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA. Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P Front Immunol; 2022; 13():919231. PubMed ID: 35967366 [TBL] [Abstract][Full Text] [Related]
38. Integrated analysis of hypoxia-associated lncRNA signature to predict prognosis and immune microenvironment of lung adenocarcinoma patients. Shao J; Zhang B; Kuai L; Li Q Bioengineered; 2021 Dec; 12(1):6186-6200. PubMed ID: 34486476 [TBL] [Abstract][Full Text] [Related]
39. Integrating multiple machine learning algorithms for prognostic prediction of gastric cancer based on immune-related lncRNAs. Li G; Huo D; Guo N; Li Y; Ma H; Liu L; Xie H; Zhang D; Qu B; Chen X Front Genet; 2023; 14():1106724. PubMed ID: 37082204 [No Abstract] [Full Text] [Related]
40. Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma. Zhuang J; Chen Z; Chen Z; Chen J; Liu M; Xu X; Liu Y; Yang S; Hu Z; He F Respir Res; 2022 May; 23(1):123. PubMed ID: 35562727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]